Sign In
Buy INO
$1.14
-0.0700 (-5.79%)
At Close: Jun 03, 2026
Inovio Plunges To 7-Month Low On Updates From Rival COVID-19 Vaccine Developers
11:15am, Monday, 09'th Nov 2020
Coronavirus vaccine developer Inovio Pharmaceuticals Inc (NASDAQ: INO)'s stock, which was rocked in September by the partial clinical hold imposed on the planned Phase 2/3 study of the company's DNA
Why Inovio Pharmaceuticals, Novavax, and Vaxart Crashed in October
10:00am, Monday, 09'th Nov 2020
These three pre-revenue COVID-19 vaccine stocks took a beating last month.
November Is a Crucial Month for this Coronavirus Vaccine Stock
07:12am, Sunday, 08'th Nov 2020
The fate of this company's late-stage trial is now in the hands of the FDA.
3 Red Flags for Inovio Pharmaceuticals' Future
06:55am, Saturday, 07'th Nov 2020
Beware the risks of investing in this small-cap COVID-19 vaccine developer.
Inovio Pharmaceuticals's Earnings: A Preview
10:20am, Friday, 06'th Nov 2020
Inovio Pharmaceuticals (NASDAQ: INO) releases its next round of earnings this Monday, November 09. Get the latest predictions in Benzinga's essential guide to the company's Q3 earnings report.
Avoid These 2 Coronavirus Innovator Stocks in November
06:25am, Wednesday, 04'th Nov 2020
These companies aren't about to win the coronavirus vaccine race, but their competitors probably will.
Inovio Responds To Partial Clinical Hold On COVID-19 Vaccine Candidate, Expects FDA Reply This Month
09:00am, Tuesday, 03'rd Nov 2020
Inovio Pharmaceuticals Inc (NASDAQ: INO) responded to the FDA's questions about INO-4800 and the Cellectra vaccine delivery device in October, the company confirmed to Benzinga. Inovio Continues Phase
Avoid Taking a Bet on the Deep Correction In Inovio Stock
02:57pm, Monday, 02'nd Nov 2020
Small-cap biotechs are inherently challenging. With a failed INO-4800 timeline, INO stock increasingly finds itself back in this group.
These 3 Popular Stocks Are More Trick Than Treat
05:51am, Saturday, 31'st Oct 2020
Think twice before buying into these businesses.
Avoid Inovio Pharmaceuticals Stock Until the FDA Greenlights Trials
05:01am, Friday, 30'th Oct 2020
While I'd like to tell you Inovio Pharmaceuticals is a blood-in-the-streets opportunity, I can't. Avoid INO stock for now.
Inovio Investors Need FDA to Write Positive Prescription for Stock Gains
11:21am, Thursday, 29'th Oct 2020
The bad news is that the FDA recently halted the Inovio trial. Think about that for a moment.
Why Coronavirus Vaccine Stocks Moderna, Novavax, and Inovio Are Sinking Today
11:58am, Wednesday, 28'th Oct 2020
The overall stock market sell-off is pulling all three biotech stocks down.
The FDA's Questions Aren't a Deal Breaker for Inovio Stock
11:11am, Tuesday, 27'th Oct 2020
INO stock is down but not out as the development of a Covid-19 vaccine is bound to have some bumps in the road. The post The FDA's Questions Aren't a Deal Breaker for Inovio Stock appeared first on In
Investors Betting on a Coronavirus Vaccine Better Know Who Gets First Dibs in Global Pact
07:07am, Tuesday, 27'th Oct 2020
The World Health Organization is managing a global vaccine program without U.S. participation, and it could have a big impact for investors.
2 Coronavirus Stocks to Avoid This Month
06:30am, Saturday, 24'th Oct 2020
Clinical trial delays and skeptical scientists spell trouble for these stocks.
